![Aadel Al-Jadda](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Aadel Al-Jadda
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Akura Medical, Inc.
![]() Akura Medical, Inc. Medical SpecialtiesHealth Technology Akura Medical, Inc. is a privately held medical device company that is developing a next-generation thrombectomy device to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots. Akura Medical is based in Campbell, CA. The company is focused on delivering an effective solution to address the major challenges of venous thromboembolism (VTE). The company was founded in 2019 by Amr Salahieh, Aadel Al-Jadda. Murali Srivathsa has been the CEO of the company since 2022. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 | - |
Gründer | 01.01.2019 | - |
Karriereverlauf von Aadel Al-Jadda
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Akura Medical, Inc.
![]() Akura Medical, Inc. Medical SpecialtiesHealth Technology Akura Medical, Inc. is a privately held medical device company that is developing a next-generation thrombectomy device to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots. Akura Medical is based in Campbell, CA. The company is focused on delivering an effective solution to address the major challenges of venous thromboembolism (VTE). The company was founded in 2019 by Amr Salahieh, Aadel Al-Jadda. Murali Srivathsa has been the CEO of the company since 2022. | Health Technology |
- Börse
- Insiders
- Aadel Al-Jadda
- Erfahrung